Yield10 Bioscience Announces Results of 2019 Field Test Program
Retrieved on:
Thursday, March 19, 2020
WOBURN, Mass., March 19, 2020 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company, today announced the results from field tests conducted in the 2019 growing season in the United States and Canada.
Key Points:
- WOBURN, Mass., March 19, 2020 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company, today announced the results from field tests conducted in the 2019 growing season in the United States and Canada.
- Yield10 also conducted field tests at sites in Canada, where field and weather conditions throughout the season posed a challenge to collecting seed yield data.
- In 2019 field trials, photosynthetic measurements were taken during the growing season on C3004 Camelina lines at similar developmental stages.
- The promising field test results associated with our triple genome-edited Camelina are a highlight of our 2019 field test program, as they clearly demonstrate that we can use CRISPR to edit gene targets in the oil biosynthesis pathway in plants to produce an increase in seed oil content, said Kristi Snell, Ph.D., Chief Science Officer of Yield10 Bioscience.